PodParley PodParley
PodParley
Episode 124: Pharma's lobbying dollars, Alnylam's future, and diversity in Covid-19 studies episode artwork

EPISODE · Aug 13, 2020 · 26 MIN

Episode 124: Pharma's lobbying dollars, Alnylam's future, and diversity in Covid-19 studies

from The Readout Loud · host STAT

Is pharma scared of Kamala Harris? Are there second acts in biotech? And why don't Covid-19 trials look more diverse?

Episode metadata supplied by the publisher feed · Published Aug 13, 2020

Embed this episode

NOW PLAYING

Episode 124: Pharma's lobbying dollars, Alnylam's future, and diversity in Covid-19 studies

0:00 26:48

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Share this episode

Similar Episodes

No similar episodes found.

Similar Podcasts

No similar podcasts found.

Frequently Asked Questions

How long is this episode of The Readout Loud?

This episode is 26 minutes long.

When was this The Readout Loud episode published?

This episode was published on August 13, 2020.

Can I download this The Readout Loud episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.
URL copied to clipboard!